67372-68-3 Usage
Uses
Used in Pharmaceutical Industry:
6,7-DeMethylene Drospirenone is used as a key intermediate in the synthesis of Drospirenone for the development of medications that address a range of medical conditions. Its importance lies in its contribution to the creation of Drospirenone, which has various therapeutic applications.
Used in Synthesis of Drospirenone:
6,7-DeMethylene Drospirenone is utilized as a vital component in the synthesis process of Drospirenon, a drug with multiple uses in the medical field. Its role in the synthesis highlights its significance in the production of effective pharmaceuticals.
Chemical Properties:
As a white solid, 6,7-DeMethylene Drospirenone exhibits specific chemical properties that make it suitable for use in the pharmaceutical industry. Its physical state and chemical composition contribute to its functionality as an intermediate in the synthesis of Drospirenone.
Check Digit Verification of cas no
The CAS Registry Mumber 67372-68-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,7,3,7 and 2 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 67372-68:
(7*6)+(6*7)+(5*3)+(4*7)+(3*2)+(2*6)+(1*8)=153
153 % 10 = 3
So 67372-68-3 is a valid CAS Registry Number.
67372-68-3Relevant academic research and scientific papers
Epoxidation of 17-oxo-15,16-methylene steroids with sulfoxonium ylides
-
Page/Page column 5, (2010/11/30)
A process for the epoxidation of 17-oxo-15,16-methylene steroids, in particular of drospirenone precursors, comprising the use of sulfoxonium ylides, in particular of dimethylsulfoxonium methyl ylide. The process allows to prepare in good yields 17-spiro epoxides, which can be easily transformed into 17-spironolacto-steroids.
Epoxidation of 17-oxo-15,16-Methylene Steroids with Sulfoxonium Ylides
-
Page/Page column 2; 4, (2010/11/30)
A process for the epoxidation of 17-oxo-15,16-methylene steroids, in particular of drospirenone precursors, comprising the use of sulfoxonium ylides, in particular of dimethylsulfoxonium methyl ylide. The process allows to prepare in good yields 17-spiro epoxides, which can be easily transformed into 17-spironolacto-steroids.
